Clinical Trials Browser

Phase 1/2 × belzutifan × 90 days × Clear all

NCT07049926 2026-05-26

MK-3475-03C

Phase 1/2 Recruiting

Carcinoma, Renal Cell

NCT04626479 2026-05-18

MK-3475-03A

Phase 1/2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT04626518 2026-05-06

KEYMAKER-U03

Phase 1/2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell